BlackRock, Inc. Increases Stake in NeoGenomics, Inc. to 14.6%

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership of 14.6% in NeoGenomics, Inc. The filing indicates that BlackRock now holds 18,861,974 shares of NeoGenomics' common stock, up from a previous amount. This represents a significant increase in both the number of shares and the value of the investment. The filing also notes that the shares were acquired in the ordinary course of business and not for the purpose of influencing the control of NeoGenomics. The amendment includes details about the ownership structure and the specific business units within BlackRock that hold these shares.